11 results

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges

  May 11, 2026

  Michael Adams

  A lawsuit alleges an Illinois woman developed CTCL after using Dupixent, raising concerns the manufacturer may have withheld concerns that the drug could contribute to cancer.

• Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy

  May 1, 2026

  Irvin Jackson

  A Dupixent lawsuit claims use of the drug led to the diagnosis of two forms of CTCL cancer, requiring repeated chemotherapy treatment and life-long medical monitoring.

• Enlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims

  March 16, 2026

  Irvin Jackson

  The makers of Dupixent face a lawsuit from a Florida woman who says she developed CTCL after just a month of injections of the atopic dermatitis treatment.

• Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks

  March 9, 2026

  Irvin Jackson

  A Georgia couple's lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma.

• Severe Sepsis Infection Leads to Vortex Port Catheter Wrongful Death Lawsuit

  January 12, 2026

  Irvin Jackson

  A husband's Vortex port catheter lawsuit claims a defective design led to his wife's death from a severe sepsis infection.

• Carvykti Black Box Warning About Gastrointestinal Risks Added By FDA

  October 13, 2025

  Irvin Jackson

  The FDA is warning that the CAR-T therapy Carvykti is linked to an increased risk of a gastrointestinal inflammation that has led to deaths due to gut perforation and sepsis.

• FDA Raises Concerns Over Carvykti and Abecma Clinical Trial Deaths Ahead of CAR-T Advisory Hearing

  March 15, 2024

  Irvin Jackson

  The FDA has submitted documents to its cancer drug advisory committee pointing to high death rates and complications among patients given the CAR-T drugs Abecma and Carvykti.

• CAR-T Therapy Drug Cancer Risks Will Be Reviewed at FDA Advisory Committee Meeting Next Month

  February 7, 2024

  Irvin Jackson

  The FDA will hold an advisory committee meeting on March 15 over the safety of some CAR-T therapy drugs, following new black box cancer warning requirements.

• FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

  January 26, 2024

  Irvin Jackson

  The FDA Found 22 cases of cancer potentially linked to CAR-T cell treatments, resulting in the recent addition of black box label warning requirements for the entire class of medications.